The IBD SmartSelect Composite Rating for ACM Research Cl A rose from 94 to 96 Tuesday.
Discover The 3 Keys To Successful Stock Investing
The new rating is a sign the stock is outpacing 96% of all stocks when it comes to the most important stock-picking criteria. History shows the top market performers tend to have a 95 or higher score as they launch their major moves.
ACM Research Cl A is currently extended beyond a proper buy zone after breaking out from a 25.61 entry in a cup with handle.
The stock has a 91 EPS Rating, meaning its recent quarterly and annual earnings growth tops 91% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
In Q1, the company posted -12% earnings growth. Top line growth came in at 13%, down from 31% in the prior quarter. The company's next quarterly report is expected on or around Aug. 6.
ACM Research Cl A holds the No. 4 rank among its peers in the Electronics-Semiconductor Equipment industry group. KLA is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
